If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr. Remy Robert is a research fellow in the Department of Molecular biology and Biochemistry (Monash University). Dr Robert is specialized in therapeutic antibody development and antibody engineering. During his PhD in Bordeaux, he developed new techniques to isolate antibodies in in vivodisease model using phage display technology. In 2007, CSIRO offered him a Postdoctoral Fellowship in the area of protein and antibody engineering. During those 3 years in Professor Pete Hudson laboratory, he mastered all the different aspects of his discipline by learning new antibody techniques. In 2011, Dr Robert joined the laboratory of Professor Charles Mackay in Monash University as a research fellow. Dr Robert’s goal is to move academic science into translation in the form of new antibody therapies using cutting-edge protein engineering techniques and human receptor knock-in mice.

Keywords

  • Antibody Therapy
  • Protein engineering
  • Inflammation
  • Autoimmunity

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2017

Research Output 2003 2019

Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms

Felizardo, R. J. F., de Almeida, D. C., Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. S., Ribeiro, W. R., Cenedeze, M. A., Hiyane, M. I., Amano, M. T., Braga, T. T., Ferreira, C. M., Parmigiani, R. B., Andrade-Oliveira, V., Volpini, R. A., Vinolo, M. A. R., Mariño, E., Robert, R., Mackay, C. R. & Camara, N. O. S., Nov 2019, (Accepted/In press) In : FASEB Journal. 33, 15 p.

Research output: Contribution to journalArticleResearchpeer-review

Gαs-coupled GPCRs GPR65 and GPR174. Downers for immune responses

Robert, R. & Mackay, C. R., 1 Apr 2018, In : Immunology and Cell Biology. 96, 4, p. 341-343 3 p.

Research output: Contribution to journalEditorialOtherpeer-review

Open Access
File

A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6

Robert, R., Juglair, L., Lim, E. X., Ang, C., Wang, C. J. H., Ebert, G., Dolezal, O. & Mackay, C. R., 5 Sep 2017, In : PLoS ONE. 12, 9, 18 p., e0184278.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice

Robert, R., Ang, C., Sun, G., Juglair, L., Lim, E. X., Mason, L. J., Payne, N. L., Bernard, C. C. A. & Mackay, C. R., 3 Aug 2017, In : JCI Insight. 2, 15, 16 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Avenues to autoimmune arthritis triggered by diverse remote inflammatory challenges

Chevalier, N., Tan, J. K., Mason, L. J., Robert, R., McKenzie, C. I., Lim, F., Wong, C. H., Macia, L., Thorburn, A. N., Russ, B. E., Masters, S. L. & Mackay, C. R., 1 Sep 2016, In : Journal of Autoimmunity. 73, p. 120-129 10 p.

Research output: Contribution to journalArticleResearchpeer-review